Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia.

Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia.

BACKGROUND: Intravenous tissue plasminogen activator (tPA) is the only approved treatment for acute ischemic stroke. Recent results from both in vitro and in vivo animal model experiments suggest the possibility that tPA is neurotoxic. METHODS: The authors evaluated the putative neurotoxicity of tPA...

Bibliografski detalji
Glavni autori:	Klein, G, Li, H, Sun, P, Buchan, A
Format:	Journal article
Jezik:	English
Izdano:	1999

Slični predmeti

MK 801 protects tissue plasminogen activator mediated neuroexcitotoxicity in permanent focal ischemia
od: Warren, D, i dr.
Izdano: (2002)

Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats.
od: Li, H, i dr.
Izdano: (2000)

CoQ10 fails to protect brain against focal and global ischemia in rats.
od: Li, H, i dr.
Izdano: (2000)

The neurotoxicity of tissue plasminogen activator?
od: Kaur, J, i dr.
Izdano: (2004)

Maturation of ischemic neuronal death following focal cerebral ischemia
od: Li, H, i dr.
Izdano: (2000)

Proscript 519, proteasome inhibitor, reduces cortical neuronal injury following focal ischemia in rats
od: Li, H, i dr.
Izdano: (2000)

Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia.
od: Li, H, i dr.
Izdano: (2001)

A new model of temporary focal neocortical ischemia in the rat.
od: Buchan, A, i dr.
Izdano: (1992)

DELAYED TREATMENT WITH THE OMEGA-CONOPEPTIDE SNX-111 PREVENTS NEURONAL INJURY FOLLOWING TRANSIENT FOCAL ISCHEMIA AND UP TO 24 HOURS AFTER GLOBAL-ISCHEMIA
od: Buchan, A, i dr.
Izdano: (1994)

THE TIME COURSE FOR INFARCTION IN A RAT MODEL OF TRANSIENT FOCAL ISCHEMIA
od: Xue, D, i dr.
Izdano: (1990)

Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?
od: Buchan, A, i dr.
Izdano: (2000)

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.
od: Harston, G, i dr.
Izdano: (2010)

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity
od: Harston, G, i dr.
Izdano: (2010)

Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.
od: Pulsinelli, W, i dr.
Izdano: (1993)

Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
od: Xue, D, i dr.
Izdano: (1992)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.
od: Nagel, S, i dr.
Izdano: (2011)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats
od: Nagel, S, i dr.
Izdano: (2011)

Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage.
od: Nagel, S, i dr.
Izdano: (2008)

Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation
od: Karbalai, H, i dr.
Izdano: (1999)

Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia.
od: Buchan, A, i dr.
Izdano: (1990)

P-31 AND H-1 SPECTROSCOPIC IMAGING STUDIES OF FOCAL ISCHEMIA IN RAT-BRAIN
od: Kozlowski, P, i dr.
Izdano: (1995)

Effect of pretreatment with Devil's Claw on locomotor activity, infarct volume, and neuronal density in focal cerebral ischemia in rats
od: Shima Shirzad, i dr.
Izdano: (2024-07-01)

Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.
od: Balami, J, i dr.
Izdano: (2013)

Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia.
od: Nagel, S, i dr.
Izdano: (2012)

TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
od: Ebers, G
Izdano: (1988)

The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats.
od: Buchan, A, i dr.
Izdano: (1991)

Gait Impairment in a Rat Model of Focal Cerebral Ischemia
od: Saara Parkkinen, i dr.
Izdano: (2013-01-01)

Effect of temperature in focal ischemia of rat brain studied by 31P and 1H spectroscopic imaging.
od: Kozlowski, P, i dr.
Izdano: (1997)

LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice.
od: Hajime Takase, i dr.
Izdano: (2017-01-01)

MR molecular imaging of early endothelial activation in focal ischemia.
od: Barber, P, i dr.
Izdano: (2004)

Impacts of N-Butylphthalide on expression of growth factors in rats with focal cerebral ischemia
od: Yan Jiang, i dr.
Izdano: (2016-01-01)

Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
od: Dzialowski, I, i dr.
Izdano: (2012)

Tissue Plasminogen Activator and DNase in Empyema REPLY
od: Rahman, N, i dr.
Izdano: (2011)

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
od: Wang, X, i dr.
Izdano: (2004)

The potential therapeutic effect of guanosine after cortical focal ischemia in rats.
od: Gisele Hansel, i dr.
Izdano: (2014-01-01)

The effects of prolonged mild hypothermia on neurogenesis following transient focal cerebral ischemia
od: Zhao, Z, i dr.
Izdano: (2004)

Fimbria/Fornix deafferentation protects CA1 neurons and enhances neurogenesis in hippocampus following global ischemia
od: Zhao, Z, i dr.
Izdano: (2003)

Comparative evaluation of the effect of postischemic hypothermia and differentiation following global ischemia on CA1 pyramidal neuronal survival
od: Kaur, J, i dr.
Izdano: (2004)

Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia.
od: Nagel, S, i dr.
Izdano: (2012)

Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
od: Demaerschalk, B, i dr.
Izdano: (2003)